These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39267762)

  • 1. Identification of cancer stem cell-related genes through single cells and machine learning for predicting prostate cancer prognosis and immunotherapy.
    Wang Y; Ma L; He J; Gu H; Zhu H
    Front Immunol; 2024; 15():1464698. PubMed ID: 39267762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the predictive value of angiogenesis-related genes for prognosis and immunotherapy response in prostate adenocarcinoma using machine learning and experimental approaches.
    Wang Y; He J; Zhao Q; Bo J; Zhou Y; Sun H; Ding B; Ren M
    Front Immunol; 2024; 15():1416914. PubMed ID: 38817605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy.
    Wang Y; Li C; He J; Zhao Q; Zhou Y; Sun H; Zhu H; Ding B; Ren M
    Front Immunol; 2024; 15():1426474. PubMed ID: 38947325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
    Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
    Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approaches.
    Wang Y; Ji B; Zhang L; Wang J; He J; Ding B; Ren M
    Biol Direct; 2024 Jun; 19(1):50. PubMed ID: 38918844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD).
    Liu S; Yu Y; Xu J; Wang Y; Li D
    Cell Biol Int; 2024 Aug; 48(8):1169-1184. PubMed ID: 38818762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging cell death patterns to predict metastasis in prostate adenocarcinoma and targeting PTGDS for tumor suppression.
    Chen B; Guo L; Wang L; Wu P; Zheng X; Tan C; Xie N; Sun X; Zhou M; Huang H; Hao N; Lei Y; Yan K; Wu D; Du Y
    Sci Rep; 2024 Sep; 14(1):21680. PubMed ID: 39289451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts.
    Zhang C; Chen T; Li Z; Liu A; Xu Y; Gao Y; Xu D
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32856039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
    Ma Z; Cheng X; Yue T; Shangguan X; Xin Z; Zhang W; Pan J; Wang Q; Xue W
    Cancer Med; 2021 Aug; 10(15):5358-5374. PubMed ID: 34128342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. tRNA-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer.
    Liu W; Yu M; Cheng S; Zhou X; Li J; Lu Y; Liu P; Ding S
    Curr Oncol; 2023 Jan; 30(1):981-999. PubMed ID: 36661724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
    Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
    Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the shared gene MXD3 signatures and biological mechanism in patients with hip pain and prostate cancer.
    Huang L; Xie Y; Jiang S; Gong B; Feng Y; Shan H
    Medicine (Baltimore); 2024 Sep; 103(37):e39592. PubMed ID: 39287260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
    Liang L; Xia W; Yao L; Wu Q; Hua L; Cheng G; Wang Z; Zhao R
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108267. PubMed ID: 34740081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.
    Lee JK; Bangayan NJ; Chai T; Smith BA; Pariva TE; Yun S; Vashisht A; Zhang Q; Park JW; Corey E; Huang J; Graeber TG; Wohlschlegel J; Witte ON
    Proc Natl Acad Sci U S A; 2018 May; 115(19):E4473-E4482. PubMed ID: 29686080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
    Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D
    Front Immunol; 2023; 14():1181370. PubMed ID: 37600770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine.
    Zheng X; Xu H; Yi X; Zhang T; Wei Q; Li H; Ai J
    Mol Cancer; 2021 Dec; 20(1):160. PubMed ID: 34872584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
    Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
    Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer.
    Zhang T; Li J; Dai J; Yuan F; Yuan G; Chen H; Zhu D; Mao X; Qin L; Liu N; Yang M
    Cancer Genet; 2023 Aug; 276-277():48-59. PubMed ID: 37487324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.